albuterol has been researched along with Orphan Diseases in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Orphan Diseases: Rare diseases that have not been well studied.
Excerpt | Relevance | Reference |
---|---|---|
"Key Words: Pulmonary alveolar proteinosis, Child, Atopy, Wheezing." | 1.72 | First Documented Case of Pulmonary Alveolar Proteinosis with Atopy Presenting Secondary to CSFR2B Mutation. ( Avci, A; Kiyan, G; Ozcan, D; Sasihuseyinoglu, AS, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sasihuseyinoglu, AS | 1 |
Ozcan, D | 1 |
Avci, A | 1 |
Kiyan, G | 1 |
1 other study available for albuterol and Orphan Diseases
Article | Year |
---|---|
First Documented Case of Pulmonary Alveolar Proteinosis with Atopy Presenting Secondary to CSFR2B Mutation.
Topics: Albuterol; Bronchoalveolar Lavage; Child; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; | 2022 |